| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0984 |
| Trial ID | ChiCTR2200058318 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Clinical trial of safety and efficacy of CD19 chimeric antigen receptor T cell in the treatment of refractory/relapsed positive B-cell malignant lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Beijing Tongren Hospital Affiliated to Capital Medical University |
| Cohort 1 | |||||||||
|
|||||||||